)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Botanix Pharmaceuticals (BOT) investor relations material
Botanix Pharmaceuticals Q4 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 TU earnings summary27 Jul, 2025
Executive summary
Q4 marked the first full quarter post-commercial launch of Softra/Sofdra, targeting primary axillary hyperhidrosis, a large and underserved US market affecting 10 million people.
Net revenue surged from $0.7M in Q3 to $4.3M in Q4, with prescriptions shipped up 324% quarter-over-quarter.
Unique prescribers increased 115% to 2,316, and new patient arrivals more than doubled to 7,053 in Q4.
Sales force expanded from 27 to 33, with further growth planned for FY26 to drive additional market penetration.
Focus remains on driving sales, optimizing operational efficiency, and achieving cash flow positivity.
Financial highlights
Total prescriptions shipped in Q4 rose 324% to 13,647 from 3,222 in Q3; unique prescribers increased 115% to 2,316.
Gross sales reached $20.4M in Q4, up from $4.8M in Q3; unaudited net revenue was $4.3M, up from $0.7M.
Operating cash outflow for the quarter was -$28.4M, mainly due to $11.2M in inventory purchases; outflows expected to decline next quarter.
Financing cash inflow totaled $65.6M, including $40M equity raise and $30.7M debt drawdown.
Year-end cash position was $64.9M, with over $27M in inventory and $15.3M undrawn debt available.
Outlook and guidance
Gross to net yield improved to 23% in June, with a target of 30–40% as scale increases.
No further significant inventory purchases expected in H1 FY26, supporting lower cash outflows.
Revenue expected to rise quarter-on-quarter as market traction grows; company anticipates reaching profitability with current resources.
No plans to raise additional capital before reaching cash flow positive, given current cash and expense trends.
What is the expected GTN range for Sofdra?
How many additional sales staff planned for Q2 FY2026?
When does Tranche B of Kreos facility expire?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Botanix Pharmaceuticals earnings date
Q1 202625 Nov, 2025
Next Botanix Pharmaceuticals earnings date
Q1 202625 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Botanix Pharmaceuticals Limited is a clinical-stage pharmaceutical company focused on developing treatments for dermatological and antimicrobial conditions. The company's pipeline leverages synthetic cannabidiol (CBD) to address skin diseases such as acne, rosacea, and atopic dermatitis, as well as infections caused by antimicrobial-resistant bacteria. Botanix’s products aim to offer innovative therapies that address unmet medical needs, especially in dermatology, by combining novel formulations with delivery systems that enhance drug efficacy. The company is headquartered in North Perth, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage